臨床試験

CIRSE Registry for LifePearl Microspheres

NCT: NCT03086096 · COMPLETED

NCT識別子NCT03086096

ステータスCOMPLETED

開始日2018-02-02

完了2022-04-30

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2017-03-22

Last updated2026-05-13

概要

The application of transarterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan in liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma will be observed. The registry has the following objectives: 1. map the exact indications that the device is being used for and at which stage in treatment it is being applied 2. to assess observed treatment outcomes in terms of safety and effectiveness as well as trying to determine any predictive response factors

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。